Medicina
Departamento
Universidad de Cantabria
Santander, EspañaPublicaciones en colaboración con investigadoras/es de Universidad de Cantabria (39)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Clinical presentation, microbiology, and prognostic factors of prosthetic valve endocarditis. Lessons learned from a large prospective registry
PloS one, Vol. 18, Núm. 9, pp. e0290998
-
Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice
Transplantation, Vol. 107, Núm. 3, pp. 762-773
2022
-
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients
Seminars in Arthritis and Rheumatism, Vol. 55
-
Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum
Clinical journal of the American Society of Nephrology : CJASN
-
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
Frontiers in Immunology, Vol. 13
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy
Clinical and experimental rheumatology, Vol. 40, Núm. 5, pp. 988-992
2021
-
Decisiones de no ingreso en las Unidades de Cuidados Intensivos como medida de limitación de los tratamientos de soporte vital: variabilidad geográfica en España
Cuadernos de bioética, Vol. 32, Núm. 104, pp. 37-48
-
HLA association with the susceptibility to anti-synthetase syndrome
Joint Bone Spine, Vol. 88, Núm. 3
-
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
Therapeutic Advances in Musculoskeletal Disease, Vol. 13
-
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome
Scientific Reports, Vol. 11, Núm. 1
-
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients
Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 2, pp. 395-403
-
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
Arthritis Research and Therapy, Vol. 23, Núm. 1
2020
-
Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis
Clinical and experimental rheumatology, Vol. 38, Núm. 6, pp. 1201-1205
-
Bacteremia in systemic lupus erythematosus in patients from a Spanish registry: Risk factors, clinical and microbiological characteristics, and outcomes
Journal of Rheumatology, Vol. 47, Núm. 2, pp. 234-240
-
Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort
The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 10, pp. 3056-3061
-
Influence of MUC5B gene on antisynthetase syndrome
Scientific Reports, Vol. 10, Núm. 1
2019
-
ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts
Rheumatology International
-
Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis
Clinical and experimental rheumatology, Vol. 37, Núm. 3, pp. 465-473